ATE182368T1 - Enzymatische racemat-spaltung von 2-piperidin- alkyl-carboxylaten - Google Patents

Enzymatische racemat-spaltung von 2-piperidin- alkyl-carboxylaten

Info

Publication number
ATE182368T1
ATE182368T1 AT94400381T AT94400381T ATE182368T1 AT E182368 T1 ATE182368 T1 AT E182368T1 AT 94400381 T AT94400381 T AT 94400381T AT 94400381 T AT94400381 T AT 94400381T AT E182368 T1 ATE182368 T1 AT E182368T1
Authority
AT
Austria
Prior art keywords
racemat
cleavage
enzymatic
piperidine
alkyl carboxylates
Prior art date
Application number
AT94400381T
Other languages
English (en)
Inventor
Serge Perard
Lydia Zard
Guy Rossey
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE182368T1 publication Critical patent/ATE182368T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94400381T 1993-03-03 1994-02-23 Enzymatische racemat-spaltung von 2-piperidin- alkyl-carboxylaten ATE182368T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302434A FR2702220B1 (fr) 1993-03-03 1993-03-03 Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse.

Publications (1)

Publication Number Publication Date
ATE182368T1 true ATE182368T1 (de) 1999-08-15

Family

ID=9444600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94400381T ATE182368T1 (de) 1993-03-03 1994-02-23 Enzymatische racemat-spaltung von 2-piperidin- alkyl-carboxylaten

Country Status (10)

Country Link
EP (1) EP0614986B1 (de)
JP (1) JPH06296498A (de)
KR (1) KR940021737A (de)
CN (1) CN1100143A (de)
AT (1) ATE182368T1 (de)
CA (1) CA2116833A1 (de)
DE (1) DE69419547D1 (de)
FI (1) FI940999L (de)
FR (1) FR2702220B1 (de)
IL (1) IL108829A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718439B3 (fr) * 1994-04-12 1996-02-09 Synthelabo Dérivés de l'acide pipécolique, leur préparation et leur utilisation comme intermédiaires de synthèse.
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
GB9924882D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel process
FR2804682B1 (fr) * 2000-02-09 2002-05-03 Rhodia Chimie Sa Procede de preparation diastereoselective de piperidines fonctionnalisees en positions 2 et 4 utilisables comme intermediaires de synthese
WO2002053536A1 (en) * 2000-12-29 2002-07-11 Chirotech Technology Ltd. Chiral scaffolds and their preparation
CN101712645B (zh) * 2009-11-20 2013-08-28 重庆威尔德·浩瑞医药化工有限公司 一种(2r,4r)-4-甲基-2-哌啶甲酸的制备方法
CN102952065A (zh) * 2011-08-24 2013-03-06 重庆华邦胜凯制药有限公司 一种拆分顺式2,3-吡啶二甲酸酯的方法
CN102719512B (zh) * 2012-06-21 2014-06-11 浙江工业大学 一种r-2-(4-羟基苯氧基)丙酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
JPS60502054A (ja) * 1983-08-01 1985-11-28 アストラ・レケメデル・アクチボラグ L―N―n―プロピルピペコリン酸―2,6―キシリダイドおよびその製造方法
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な1,4−ジヒドロピリジン化合物及びその製造方法

Also Published As

Publication number Publication date
FR2702220A1 (fr) 1994-09-09
CA2116833A1 (fr) 1994-09-04
CN1100143A (zh) 1995-03-15
FR2702220B1 (fr) 1995-05-12
FI940999A7 (fi) 1994-09-04
EP0614986B1 (de) 1999-07-21
EP0614986A1 (de) 1994-09-14
IL108829A (en) 1999-03-12
FI940999L (fi) 1994-09-04
JPH06296498A (ja) 1994-10-25
DE69419547D1 (de) 1999-08-26
FI940999A0 (fi) 1994-03-02
IL108829A0 (en) 1994-06-24
KR940021737A (ko) 1994-10-19

Similar Documents

Publication Publication Date Title
ATE137535T1 (de) Enzymatisches verfahren zur herstellung von 7- aminocephalosporinsäure und derivate
PT1418170E (pt) Processo para a preparacao de aminoalcoois opticamente activos por meio de separacao do racemato
ATE182368T1 (de) Enzymatische racemat-spaltung von 2-piperidin- alkyl-carboxylaten
DE68906904D1 (de) Verfahren zur herstellung von optisch aktiven 2-arylalkansaeuren.
DE69111511D1 (de) Biokatalytisches Verfahren zur Herstellung von L-(-)-Carnitin aus Crotonobetain und Stämme von Proteeae zur Verwendung in diesem Verfahren.
EP1484322A4 (de) Verfahren zur herstellung eines optisch aktiven sulfoxid derivats
DE50209620D1 (de) Verfahren zur Herstellung von kristallinem Cholinascorbat
PT100159A (pt) Processo para a preparacao de trans-piperidino-2,5-dicarboxilatos
PT89282A (pt) Processo para a hidrolise enzimatica de monoaminocompostos de alfa-aminoadipinilo
DE3779403D1 (de) Enzymatisches verfahren zur herstellung von 3-substituierten cephalosporinen.
ATE439333T1 (de) Verfahren zur herstellung optisch aktiver propoxyanilinderivate
BR8701422A (pt) Processo para separacao biotecnologica,efetuada por meio de enzimas,de isomeros opticos(r)e(s)de 2-amino-1 alcanois racemicos
ATE248225T1 (de) Verfahren zur herstellung von (s)-3-halogeno-1,2- propandiol durch pseudomonas
ATE238261T1 (de) Verfahren zur herstellung von orthoestern
ATE304606T1 (de) Verfahren zur enzymatischen herstellung von enantiomerenreinen 1,3-dioxolan-4-on- und 1,3- oxathiolan-5-on-derivaten
DE3585721D1 (de) Verfahren zur herstellung von substituierten piperidinen.
ATE264918T1 (de) Verfahren zur herstellung von optisch aktivem 1,2,4-butantriol und optisch aktivem 3-hydroxy-gamma- butyrolacton mittels microorganismen
ATE155819T1 (de) Verfahren zur herstellung von optisch aktivem vinylglycin in freier oder geschützter form über eine enzymatische, enantioselektive hydrolyse
ATE178324T1 (de) Verfahren zur herstellung von enantiomeren von dropropizin
ATE223391T1 (de) Verfahren zur herstellung von (s)-3-methyl-1-(2- piperidino-phenyl)-1-butylamin
DE69226942D1 (de) Verfahren zur herstellung von optisch aktivem norborneol
ATE253125T1 (de) Verfahren zur herstellung von optisch aktiven 1- amino-4- (hydroxymethyl)- cyclopent-2- en- derivaten
DE69818133D1 (de) Herstellung von einer optisch-aktiven Sphingoid-Verbindung
ATE286881T1 (de) Verfahren zur zyklisierung von optisch aktiven 4- amino-2-halogenbuttersäuren
DE3780137D1 (de) Verfahren zur herstellung von optisch aktiven bicyclo (3.3.0) octandioncarbonsaeureestern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties